Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration

Márta Marschalkó, Nóra Eros, Péter Holló, Judit Hársing, Gyula Bottlik, Árpád Bátai, Zoltán Csukly, Tamás Masszi, Zoltán Szentirmai, János Fodor, Sarolta Kárpáti, András Matolcsy, Judit Csomor

Research output: Article

6 Citations (Scopus)

Abstract

A 49 year-old man presented to our clinic. He had a history of lymphomatoid papulosis since childhood. At age 44, regional lymph node manifestation of anaplastic lymphoma kinase (ALK) anaplastic large cell lymphoma (ALCL) developed. Chemotherapy resulted in complete remission of the lymphadenopathy. Four years later, systemic relapse was detected which was refractory to therapy. Histology and immunohistochemistry showed congruent characteristics of multiple skin and lymph node biopsies: diffuse mixed infiltrate with large, anaplastic CD30 cells. Immunophenotype and microscopic morphology suggested a common origin of the different manifestations-however, this could not be proven due to lack of T-cell receptor (TCR) gamma gene rearrangement in most of the samples. The diagnosis of ALK-negative systemic ALCL with cutaneous symptoms was set up at the second flare up, however, the possibility of primary cutaneous ALCL was not excluded steadily. Lymphomatoid papulosis, primary cutaneous ALCL, and systemic ALK ALCL are 3 different entities but the separation of them cannot be solved without distinctive diagnostic tools.

Original languageEnglish
Pages (from-to)708-712
Number of pages5
JournalAmerican Journal of Dermatopathology
Volume32
Issue number7
DOIs
Publication statusPublished - okt. 1 2010

    Fingerprint

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dermatology

Cite this